Inmolecule Nanotech, S.A. (EPA:MLINA)

Market Cap	30.60M +6.8%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	7.50M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	4.080
Day's Range	n/a
52-Week Range	3.820 - 4.080
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Inmolecule Nanotech

Inmolecule Nanotech, S.A., a biotech company, develops active ingredient nano particles for various applications in the home and personal care, agriculture, aquaculture, and pharmaceutical industries. The company provides Nano-Phyto-Chemistry platform that utilizes plant extracts at the nanometric scale to eliminate infectious germs, including viruses, fungi, bacteria, spores, and mycobacteria, and others. Its products include surface sanitizers/disinfectants, and vitamin C and zinc dietary supplements. The company was founded in 1999 and is ba...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1999
• Country: Spain
• Stock Exchange: Euronext Paris
• Ticker Symbol: MLINA

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 29, 2026

Data Sources Report a data error